Growth hormone activated STAT5 is required for induction of beige fat in vivo. (October 2018)
- Record Type:
- Journal Article
- Title:
- Growth hormone activated STAT5 is required for induction of beige fat in vivo. (October 2018)
- Main Title:
- Growth hormone activated STAT5 is required for induction of beige fat in vivo
- Authors:
- Nelson, Caroline N.
List, Edward O.
Ieremia, Makerita
Constantin, Lena
Chhabra, Yash
Kopchick, John J.
Waters, Michael J. - Abstract:
- Abstract: Objective: The anti-obesity actions of growth hormone (GH) led us to investigate if GH signaling is able to regulate beige/brite fat development of white adipose tissue (WAT). Methods: We studied WAT in GHR-391 mice engineered to be unable to activate STAT5 in response to GH, in mice with adipose specific deletion of GHR, in GHR−/− mice and in bGH transgenic mice. QPCR, immunoblots and immunohistochemistry were used to characterize WAT. The in vivo effects of β-3 adrenergic activation with CL-316, 243 and that of FGF21 infusion were also studied. Results: GHR-391 mice had lower surface temperature than WT, with deficiency in β-oxidation and beiging transcripts including Ucp1. Oxidative phosphorylation complex subunit proteins were decreased dramatically in GHR-391 inguinal white adipose tissue (iWAT), but increased in bGH iWAT, as were proteins for beige/brown markers. In accord with its lack of β-3 adrenergic receptors, iWAT of GHR-391 mice did not beige in response to administration of the β-3 specific agonist CL-316, 243 in contrast to WT mice. GHR-391 mice are deficient in FGF21, but unlike WT, infusion of the purified protein was without effect on extent of beiging. Finally, fat-specific deletion of the GHR replicated the loss of beiging associated transcripts. Conclusion: In addition to promoting lipolysis, our study suggests that GH is able to promote formation of beige adipose tissue through activation of STAT5 and induction of Adrb3. This sensitizes WAT toAbstract: Objective: The anti-obesity actions of growth hormone (GH) led us to investigate if GH signaling is able to regulate beige/brite fat development of white adipose tissue (WAT). Methods: We studied WAT in GHR-391 mice engineered to be unable to activate STAT5 in response to GH, in mice with adipose specific deletion of GHR, in GHR−/− mice and in bGH transgenic mice. QPCR, immunoblots and immunohistochemistry were used to characterize WAT. The in vivo effects of β-3 adrenergic activation with CL-316, 243 and that of FGF21 infusion were also studied. Results: GHR-391 mice had lower surface temperature than WT, with deficiency in β-oxidation and beiging transcripts including Ucp1. Oxidative phosphorylation complex subunit proteins were decreased dramatically in GHR-391 inguinal white adipose tissue (iWAT), but increased in bGH iWAT, as were proteins for beige/brown markers. In accord with its lack of β-3 adrenergic receptors, iWAT of GHR-391 mice did not beige in response to administration of the β-3 specific agonist CL-316, 243 in contrast to WT mice. GHR-391 mice are deficient in FGF21, but unlike WT, infusion of the purified protein was without effect on extent of beiging. Finally, fat-specific deletion of the GHR replicated the loss of beiging associated transcripts. Conclusion: In addition to promoting lipolysis, our study suggests that GH is able to promote formation of beige adipose tissue through activation of STAT5 and induction of Adrb3. This sensitizes WAT to adrenergic input, and may contribute to the anti-obesity actions of GH. Highlights: Removal of the growth hormone receptor (GHR) prevents beiging of white adipose tissue (WAT) in mice. Removal of the portion of the GHR responsible for STAT-5 signaling also prevents beiging of WAT in mice. Beiging of WAT by GH is mediated largely through induction of beta3 adrenergic receptors, likely by STAT5. … (more)
- Is Part Of:
- Growth hormone & IGF research. Volume 42/43(2018)
- Journal:
- Growth hormone & IGF research
- Issue:
- Volume 42/43(2018)
- Issue Display:
- Volume 42/43, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 42/43
- Issue:
- 2018
- Issue Sort Value:
- 2018-NaN-2018-0000
- Page Start:
- 40
- Page End:
- 51
- Publication Date:
- 2018-10
- Subjects:
- Growth hormone -- Adipose beiging -- b3-adrenergic -- FGF 21 -- Obesity -- Mouse
Growth regulators -- Periodicals
Growth -- Regulation -- Periodicals
Somatomedin -- Periodicals
Somatomedins -- Periodicals
Growth Hormone -- Periodicals
Growth Substances -- Periodicals
Croissance -- Régulation -- Périodiques
Croissance -- Régulateurs -- Périodiques
Somatotrophine -- Périodiques
Somatomédine -- Périodiques
Growth -- Regulation
Growth regulators
Electronic journals
Periodicals
Electronic journals
612.4 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10966374 ↗
http://www.growthhormoneigfresearch.com/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10966374 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/10966374 ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/cgi-bin/links/toc/ghir ↗
http://www.harcourt-international.com/journals/ghir/ ↗ - DOI:
- 10.1016/j.ghir.2018.08.004 ↗
- Languages:
- English
- ISSNs:
- 1096-6374
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4223.033700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8585.xml